Fox Chase Chemical Diversity Center, Inc.
Jay E. Wrobel, Ph.D., is vice president of academic relations at Fox Chase Chemical Diversity Center, Inc. Wrobel has led the medicinal chemistry efforts in the Phase I STTR collaboration of FCCDC with PI Ron Harty of the University of Pennsylvania in the area of virus assembly and budding. Wrobel received his Ph.D. in chemistry at Cornell University and was previously employed by Wyeth Pharmaceuticals (now Pfizer) for 27 years where he was a senior director mentoring a group of medicinal chemists and managing various drug discovery projects. Wrobel has been engaged in structure activity studies and drug optimization research in a variety of therapeutic areas including antiviral/anti-infective diseases, oncology, and metabolic, endocrinology and cardiovascular disorders. Wrobel is a co-author on 74 peer-reviewed scientific publications and inventor on 78 issued U.S. patents.
The appearance of an author or a presenter on this DTIC website should not necessarily be construed as association of this individual with the United States Department of Defense (DoD), and the views, information, or opinions expressed herein are those of the author or presenter and do not necessarily constitute endorsement by the United States Department of Defense (DoD).